March 2, 2024

For the first time since Brex­it, the UK’s med­i­cines reg­u­la­tor has made use of its new ap­proval path­way that can speed drug ap­provals based on

A fed­er­al judge in Delaware on Fri­day ruled in fa­vor of the Biden ad­min­is­tra­tion in a case brought by As­traZeneca seek­ing to over­turn parts of

Mod­er­na has made cuts at its Burling­ton and Nor­wood sites in Mass­a­chu­setts, a spokesper­son con­firmed to End­points News, in­clud­ing some work­ers in qual­i­ty as­sur­ance. “Mod­er­na pre­vi­ous­ly

Plus, news about Tar­sus Phar­ma­ceu­ti­cals, Hu­ma­cyte, Stem­cell Tech­nolo­gies and SQZ Biotech­nolo­gies: Achieve Life Sci­ences rais­es $124M, de­tails plans for NDA: The com­pa­ny plans to sub­mit

In a bid to over­come some of the com­mer­cial chal­lenges faced by ex­pen­sive new gene ther­a­pies, Quan­tile Health has raised $6 mil­lion for a fi­nan­cial

Fog­Phar­ma, a biotech from Har­vard re­searcher Greg Ver­dine that is led by for­mer John­son & John­son R&D leader Math­ai Mam­men, said it has raised $145

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)  As weight loss drugs boom in pop­u­lar­i­ty,

Share this article The diagnostic industry is growing and evolving – picking the right partnerships can help with the process of navigating change. Credit: Mongkolchon

WASHINGTON — Although FDA approval has eluded the intranasal epinephrine spray ARS-1 (also known as neffy), it continued to build its case with findings of

More than 90% of patients with locally advanced basal cell carcinoma (BCC) of the head and neck achieved locoregional control (LRC) with vismodegib (Erivedge) and